Adrian B McDermott
Adrian B McDermott
Chief, Vaccine Immunology Program, Vaccine Research Center, NIAID-NIH
Verified email at - Homepage
Cited by
Cited by
An mRNA vaccine against SARS-CoV-2—preliminary report
LA Jackson, EJ Anderson, NG Rouphael, PC Roberts, M Makhene, ...
New England journal of medicine 383 (20), 1920-1931, 2020
Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults
EJ Anderson, NG Rouphael, AT Widge, LA Jackson, PC Roberts, ...
New England Journal of Medicine 383 (25), 2427-2438, 2020
Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
KS Corbett, B Flynn, KE Foulds, JR Francica, S Boyoglu-Barnum, ...
New England Journal of Medicine 383 (16), 1544-1555, 2020
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ...
Science 375 (6576), 43-50, 2022
Durability of responses after SARS-CoV-2 mRNA-1273 vaccination
AT Widge, NG Rouphael, LA Jackson, EJ Anderson, PC Roberts, ...
New England Journal of Medicine 384 (1), 80-82, 2021
Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19
N Doria-Rose, MS Suthar, M Makowski, S O’Connell, AB McDermott, ...
New England Journal of Medicine 384 (23), 2259-2261, 2021
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants
A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ...
Science 373 (6561), 1372-1377, 2021
Homologous and heterologous Covid-19 booster vaccinations
RL Atmar, KE Lyke, ME Deming, LA Jackson, AR Branche, HM El Sahly, ...
New England Journal of Medicine 386 (11), 1046-1057, 2022
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
RM Lynch, E Boritz, EE Coates, A DeZure, P Madden, P Costner, ...
Science translational medicine 7 (319), 319ra206-319ra206, 2015
Crystal structure, conformational fixation and entry-related interactions of mature ligand-free HIV-1 Env
Y Do Kwon, M Pancera, P Acharya, IS Georgiev, ET Crooks, J Gorman, ...
Nature structural & molecular biology 22 (7), 522-531, 2015
Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site
M Kanekiyo, W Bu, MG Joyce, G Meng, JRR Whittle, U Baxa, T Yamamoto, ...
Cell 162 (5), 1090-1100, 2015
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
DR Casimiro, F Wang, WA Schleif, X Liang, ZQ Zhang, TW Tobery, ...
Journal of virology 79 (24), 15547-15555, 2005
Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses
MG Joyce, AK Wheatley, PV Thomas, GY Chuang, C Soto, RT Bailer, ...
Cell 166 (3), 609-623, 2016
HIV vaccine design: insights from live attenuated SIV vaccines
WC Koff, PR Johnson, DI Watkins, DR Burton, JD Lifson, KJ Hasenkrug, ...
Nature immunology 7 (1), 19-23, 2006
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
NA Wilson, J Reed, GS Napoe, S Piaskowski, A Szymanski, J Furlott, ...
Journal of virology 80 (12), 5875-5885, 2006
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
K Xu, P Acharya, R Kong, C Cheng, GY Chuang, K Liu, MK Louder, ...
Nature medicine 24 (6), 857-867, 2018
Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
Clinical & Experimental Immunology 182 (3), 289-301, 2015
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
NK Kisalu, AH Idris, C Weidle, Y Flores-Garcia, BJ Flynn, BK Sack, ...
Nature medicine 24 (4), 408-416, 2018
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates
KS Corbett, MC Nason, B Flach, M Gagne, S O’Connell, TS Johnston, ...
Science 373 (6561), eabj0299, 2021
Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
M Kanekiyo, MG Joyce, RA Gillespie, JR Gallagher, SF Andrews, ...
Nature immunology 20 (3), 362-372, 2019
The system can't perform the operation now. Try again later.
Articles 1–20